Treatment of pulmonary fibrosis in systemic sclerosis: light at the end of the tunnel?
Wollheim
Frank A
FA
D000818:Animals; D001549:Benzamides; D004195:Disease Models, Animal; D005355:Fibrosis / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011658:Pulmonary Fibrosis / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D011743:Pyrimidines / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy / Q000209:etiology / Q000276:immunology
D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate